Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data sources
1.5.1 Primary
1.5.2 Secondary
1.5.2.1 Paid sources
1.5.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing prevalence of various neurological disorders and traumatic accidents
3.2.1.2 Advancements in new technologies
3.2.1.3 Growing government initiatives and policies
3.2.1.4 Rising awarenwess and screening programs
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost associated with these monitoring devices
3.2.2.2 Related complications and adverse effects
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Offering, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Products & systems
5.3 Solutions & platforms
Chapter 6 Market Estimates and Forecast, By Technology, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Invasive
6.2.1 External ventricular drainage (EVD)
6.2.2 Microtransducer ICP monitoring
6.3 Non-invasive
6.3.1 Transcranial doppler ultrasonography
6.3.2 Tympanic membrane displacement (TMD)
6.3.3 Optic nerve sheath diameter
6.3.4 MRI/CT
6.3.5 Electroencephalography
6.3.6 Fundoscopy (Papilledema)
Chapter 7 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Traumatic brain injury
7.3 Intracerebral hemorrhage
7.4 Meningitis
7.5 Subarachnoid hemorrhage
7.6 CSF management
7.7 Migraine
7.8 Stroke
7.9 Hydrocephalus
7.10 Other applications
Chapter 8 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 Hospitals
8.3 Clinics
8.4 Diagnostic laboratories
8.5 Other end-users
Chapter 9 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.4.6 Rest of Asia Pacific
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.5.4 Rest of Latin America
9.6 Middle East and Africa
9.6.1 Saudi Arabia
9.6.2 South Africa
9.6.3 UAE
9.6.4 Rest of Middle East and Africa
Chapter 10 Company Profiles
10.1 Brain4Care Inc.
10.2 CranioSense, LLC.
10.3 HeadSense Medical Ltd
10.4 Integra LifeScience Holdings Corporation
10.5 Johnson & Johnson
10.6 Luciole Medical AG
10.7 Medtronic plc
10.8 Natus Medical Incorporated
10.9 RAUMEDIC AG
10.10 Sophysa
10.11 Vittamed Corporation
